Why healthcare, housing and college tuition are now so expensive The United States by any money-based standard is a wealthy country. Yet much of its population struggles financially—and this struggling subset extends well beyond the demographic groups that are traditionally dependent on handouts. Around 50 million people in the US use food banks, implying thatRead More| JAMES THE OBSCURE
By Gerry Harriman, CSO and co-founder of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC As scientists, we are accustomed to learning something new about targets (and the modulation thereof) that moves the field forward in The post A “Complex” Solution to a “Complex” Problem? Attacking KRASG12X Colorectal Cancer Through the CBM Signalosome appeared first on LifeSciVC.| LifeSciVC
What is the true cause of American Performative Violence? On a recent Saturday in always-sunny Palm Springs, California, a 25-year-old who could have been your son or mine drove his car into a parking lot behind a fertility clinic and set off a homemade bomb within the car, in an effort to obliterate the clinicRead More| JAMES THE OBSCURE
By Ram Aiyar, CEO of Korro Bio, as part of the From The Trenches feature of LifeSciVC It has been an extraordinary journey so far and one that continues to humble, inspire and motivate me every day. I’ve had the The post Building Korro Bio: A CEO’s Perspective on Innovation and Risk Management appeared first on LifeSciVC.| LifeSciVC
By Cody Tranbarger, EIR at Atlas Venture, as part of the From The Trenches feature of LifeSciVC It’s an interesting time to be thinking about space. Just a few months ago, SpaceX captivated and inspired the world by catching a The post Boosters and Biologics: Is Space-Based Biomanufacturing Real? appeared first on LifeSciVC.| LifeSciVC
By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC Drug discovery and development is a long, and often fraught, journey – it typically takes more than a decade to progress from idea The post Frameworks for Decision-Making & Lessons Learned from “Failing Fast” appeared first on LifeSciVC.| LifeSciVC
By Arthur Tzianabos, CEO of Lifordi Immunotherapeutics, as part of the From The Trenches feature of LifeSciVC Given everything going on in our world right now, I’ve been thinking a lot about the state of biotech innovation…particularly as we wrestle| LifeSciVC
By Cody Tranbarger, EIR at Atlas Venture, as part of the From The Trenches feature of LifeSciVC For decades, muscular dystrophy has stubbornly persisted among the most intractable categories of human disease. Despite recent progress with AAV Gene Therapy and The post Dancing with the DGC: Structural Biology Meets Muscular Dystrophy appeared first on LifeSciVC.| LifeSciVC
What if science is becoming toxic to human society? In the summer of 1950, Nobel-winning nuclear physicist Enrico Fermi didn’t understand the scale of the cosmos as we understand it today. But he knew that it was at least hundreds of millions of light-years across, encompassing thousands of galaxies and more than a trillionRead More| JAMES THE OBSCURE
By Jonathan Montagu, CEO of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC In the perpetual and never-ending race by the healthcare sector to unearth new approaches and therapeutics to address disease, one area in which The post A New Wave of Therapeutic Innovation Through Targeting Transcription Factors appeared first on LifeSciVC.| LifeSciVC
By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC “It was the best of times, it was the worst of times…” Another JPM is behind us, and while much of the small The post A Tale of Two Sentiments: JPM 2025 appeared first on LifeSciVC.| LifeSciVC